glp-1 agonists for weight loss What Are Loss? Weight Loss and Maintenance Related

Moreover, peptides in GLP-1 drugs are derived from living cells through recombinant DNA technology, which makes their manufacturing process more complex and expensive than traditional pills

10.1210/en.2011-1443 3 BaisleyS

Diabetes Care 44, 14331442

In diabetes care, endocrinologists bring deep knowledge of insulin dynamics, complication management, and complex pharmacotherapy

Putting orforglipron in context Because obesity therapies are evolving rapidly in a market dominated by injectables since semaglutides weight-loss approval in 2021, it is helpful to view orforglipron alongside established and emerging incretin-based drugs

However, pairing GLP-1 drugs with DPP-4 inhibitors is generally avoided since both act on the same pathway, resulting in overlapping effects without meaningful added benefits